Profile data is unavailable for this security.
About the company
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. It owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.
- Revenue in USD (TTM)287.75m
- Net income in USD127.58m
- Incorporated2008
- Employees311.00
- LocationInmode LtdTavor Building, Sha'ar Yokneam, Pob 533YOKNEAM 2069200IsraelISR
- Phone+972 49097470
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Axonics Inc | 119.61m | -62.80m | 3.10bn | 416.00 | -- | 8.66 | -- | 25.91 | -1.64 | -1.64 | 3.11 | 7.89 | 0.3612 | 1.07 | 5.66 | 287,528.80 | -18.96 | -- | -20.31 | -- | 59.43 | -- | -52.50 | -- | 6.53 | -42.52 | 0.1855 | -- | 707.06 | -- | 31.30 | -- | -- | -- |
| NuVasive, Inc. | 1.15bn | 1.85m | 3.26bn | 2.70k | 1,823.36 | 3.88 | 22.23 | 2.83 | 0.0346 | 0.0346 | 22.31 | 16.28 | 0.4808 | 1.01 | 5.78 | 427,098.50 | 0.0773 | 1.55 | 0.0973 | 1.81 | 72.31 | 72.62 | 0.1607 | 2.57 | 2.30 | 1.82 | 0.5121 | 0.00 | -10.06 | 5.31 | -156.95 | -- | 0.3312 | -- |
| Integer Holdings Corp | 1.04bn | 67.68m | 3.29bn | 7.50k | 48.78 | 2.57 | 22.23 | 3.17 | 2.04 | 2.04 | 31.25 | 38.75 | 0.4368 | 4.70 | 4.61 | 138,064.40 | 2.85 | 2.29 | 3.08 | 2.47 | 26.41 | 29.44 | 6.54 | 5.19 | 1.58 | 2.71 | 0.3497 | 0.00 | -14.68 | 6.05 | -15.30 | -- | 2.89 | -- |
| Owens & Minor, Inc. | 8.68bn | 166.57m | 3.45bn | 6.30k | 18.71 | 4.38 | 13.32 | 0.3972 | 2.45 | 1.54 | 131.53 | 10.47 | 2.44 | 5.95 | 12.37 | 1,378,416.00 | 4.69 | -1.10 | 7.90 | -1.80 | 16.76 | 12.65 | 1.92 | -0.3948 | 0.6609 | 5.19 | 0.5552 | -- | -7.93 | -2.80 | 489.98 | -2.99 | 10.08 | -60.27 |
| Merit Medical Systems, Inc. | 969.26m | 4.27m | 3.64bn | 5.99k | 916.56 | 3.72 | 37.70 | 3.75 | 0.0708 | 0.0708 | 17.35 | 17.46 | 0.57 | 2.62 | 6.45 | 161,840.50 | 0.2510 | 1.36 | 0.282 | 1.52 | 42.23 | 43.60 | 0.4404 | 2.17 | 1.15 | 7.40 | 0.247 | 0.00 | -3.11 | 12.20 | -280.57 | -- | -1.41 | -- |
| AtriCure Inc. | 212.58m | -48.66m | 3.82bn | 750.00 | -- | 9.75 | -- | 17.95 | -1.13 | -1.13 | 4.93 | 8.58 | 0.3463 | 1.69 | 8.20 | 283,441.30 | -7.93 | -8.44 | -8.61 | -9.35 | 72.90 | 72.67 | -22.89 | -17.00 | 4.48 | -10.17 | 0.1333 | -- | -10.52 | 9.74 | -36.83 | -- | -17.12 | -- |
| Conmed Corp | 978.50m | 54.14m | 4.02bn | 3.40k | 79.77 | -- | 31.82 | 4.10 | 1.73 | 1.73 | 31.79 | -- | -- | -- | -- | 287,794.40 | -- | 1.60 | -- | 1.79 | 55.29 | 54.66 | 5.53 | 2.75 | -- | 2.40 | -- | 96.80 | -9.70 | 3.70 | -66.75 | -20.78 | -2.81 | 0.00 |
| ICU Medical Inc | 1.26bn | 93.77m | 4.25bn | 7.90k | 46.18 | 2.79 | 23.53 | 3.37 | 4.34 | 4.34 | 58.33 | 71.76 | 0.7037 | 2.64 | 7.91 | 159,549.80 | 5.24 | 5.28 | 6.16 | 6.07 | 35.92 | 37.99 | 7.44 | 6.28 | 3.49 | 989.93 | 0.0019 | 0.00 | 0.3788 | 30.05 | -14.02 | 14.07 | 48.43 | -- |
| LivaNova PLC | 1.02bn | -379.12m | 4.34bn | 4.00k | -- | 4.17 | -- | 4.25 | -7.79 | -7.80 | 20.97 | 21.24 | 0.4171 | 2.33 | 5.55 | 255,431.00 | -15.47 | -4.59 | -19.29 | -5.53 | 65.30 | 64.85 | -37.09 | -11.05 | 0.9711 | -0.6777 | 0.3892 | -- | -13.83 | -- | -120.85 | -- | -- | -- |
| Premier Inc | 1.58bn | 212.30m | 4.37bn | 2.50k | 19.22 | 1.97 | 9.49 | 2.76 | 1.86 | 1.86 | 15.16 | 18.11 | 0.4692 | 5.56 | 3.85 | 632,956.00 | 9.86 | 17.32 | 12.77 | 21.39 | 51.94 | 68.03 | 21.01 | 33.54 | 0.7785 | 14.03 | 0.2209 | 0.00 | 6.73 | 5.23 | 165.12 | -- | 5.94 | -- |
| Inmode Ltd | 287.75m | 127.58m | 4.43bn | 311.00 | 38.74 | 13.38 | 34.60 | 15.40 | 2.99 | 2.99 | 6.76 | 8.67 | 0.9267 | 2.54 | 21.43 | 925,241.20 | 41.10 | -- | 46.32 | -- | 85.14 | -- | 44.35 | -- | 8.49 | -- | 0.00 | -- | 31.81 | -- | 22.71 | -- | -- | -- |
| Inari Medical Inc | 170.12m | 17.15m | 4.47bn | 456.00 | 411.26 | 20.88 | 235.32 | 26.26 | 0.2187 | 0.2187 | 3.55 | 4.31 | 1.16 | 1.59 | 7.40 | 373,059.20 | 11.66 | -- | 12.95 | -- | 91.17 | -- | 10.08 | -- | 10.07 | 58.35 | 0.00 | -- | 173.17 | -- | 1,256.96 | -- | -- | -- |
| Inspire Medical Systems Inc | 134.39m | -57.17m | 4.87bn | 317.00 | -- | 21.80 | -- | 36.20 | -2.14 | -2.14 | 5.01 | 8.20 | 0.612 | 2.18 | 8.22 | 423,930.60 | -26.04 | -- | -28.16 | -- | 84.89 | 82.51 | -42.54 | -50.62 | 12.84 | -34.49 | 0.10 | -- | 40.62 | 70.48 | -72.08 | -- | 47.98 | -- |
| Novanta Inc (USA) | 597.74m | 43.88m | 4.87bn | 2.20k | 111.93 | 10.22 | 58.85 | 8.14 | 1.23 | 1.23 | 16.74 | 13.46 | 0.7056 | 3.46 | 6.66 | 271,699.50 | 5.18 | 6.44 | 6.09 | 7.67 | 41.63 | 42.06 | 7.34 | 7.96 | 1.87 | 7.70 | 0.2935 | 0.00 | -5.67 | 9.59 | 9.19 | 4.56 | 13.64 | -- |
| Nevro Corp | 363.19m | -87.74m | 5.37bn | 843.00 | -- | 14.64 | -- | 14.80 | -2.56 | -2.56 | 10.57 | 10.56 | 0.5879 | 1.23 | 5.55 | 430,831.60 | -14.20 | -12.91 | -18.90 | -15.32 | 69.73 | 69.17 | -24.16 | -17.96 | 2.65 | -2.35 | 0.4624 | -- | -7.23 | 39.07 | 19.89 | -- | 3.77 | -- |
| Helen of Troy Limited | 2.22bn | 250.63m | 5.47bn | 1.77k | 22.75 | 4.55 | 19.01 | 2.47 | 9.98 | 9.98 | 88.75 | 49.88 | 1.03 | 3.06 | 6.00 | 1,254,487.00 | 11.59 | 9.55 | 14.80 | 11.73 | 43.65 | 42.29 | 11.29 | 10.48 | 0.9024 | 26.43 | 0.2983 | -- | 22.92 | 8.55 | 58.79 | 21.34 | 42.70 | -- |
Data as of Jul 30 2021. Currency figures normalised to Inmode Ltd's reporting currency: US Dollar USD
19.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Acadian Asset Management LLCas of 31 Mar 2021 | 1.58m | 4.14% |
| Van Berkom & Associates, Inc.as of 31 Mar 2021 | 1.06m | 2.79% |
| Menora Mivtachim Insurance Ltd.as of 31 Mar 2021 | 1.00m | 2.63% |
| William Blair Investment Management LLCas of 31 Mar 2021 | 702.86k | 1.84% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2021 | 625.44k | 1.64% |
| Marshall Wace Asia Ltd.as of 31 Mar 2021 | 536.41k | 1.41% |
| American Century Investment Management, Inc.as of 31 Mar 2021 | 506.77k | 1.33% |
| Renaissance Technologies LLCas of 31 Mar 2021 | 486.68k | 1.27% |
| Putnam Investment Management LLCas of 31 Mar 2021 | 440.52k | 1.15% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Mar 2021 | 419.11k | 1.10% |
More ▼
Data from 31 Mar 2021 - 31 Mar 2021Source: FactSet Research Systems Inc.
